Skip to content

Net Income at other companies

NeoGenomics logo
NeoGenomicsNEO
-$17.11M+34.0%
Veracyte logo
VeracyteVCYT
$28.71M+307%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
-$20.03M+32.9%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$30.03M-90.7%
Guardant Health logo
Guardant HealthGH
-$112.08M-17.8%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-$125.92M-85.1%

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s net income?
Biodesix, Inc. (BDSX) reported net income of -$7.79M in Q1 2026.
How has Biodesix, Inc.'s net income changed year-over-year?
Biodesix, Inc.'s net income increased by 29.8% year-over-year, from -$11.1M to -$7.79M.
What is the long-term trend for Biodesix, Inc.'s net income?
Over 4 years (2021 to 2025), Biodesix, Inc.'s net income has grown at a -4.9% compound annual growth rate (CAGR), from -$43.16M to -$35.27M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.